首页 > 市场调查报告书 > 製药

儿科安宁疗护药物市场：依药物类别、给药途径、通路、地区：规模、份额、前景、机会分析，2023-2030

市场调查报告书

商品编码

1350265

儿科安宁疗护药物市场：依药物类别、给药途径、通路、地区：规模、份额、前景、机会分析，2023-2030

Pediatric Palliative Care Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023-2030

出版日期: 2023年08月24日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球儿科安宁疗护药物市场规模将达到 831 亿美元，预计在预测期内（2023-2030 年）复合年增长率为 5.1%。

报告范围		报告详情
基准年	2022年	2023年市场规模	美国：831亿美元
之前的数据	2018年至2021年	预测期	2023-2030
预测 2023-2030 年复合年增长率：	5.10%	2030年价值预测	1178亿美元

儿科安宁疗护是针对患有严重疾病的儿童的专门医疗照护。安宁疗护的重点是缓解疾病症状和压力。目的是提高儿童和家庭的生活品质。儿科安宁疗护适用于任何年龄和疾病阶段。适用于新生儿、围产期、婴儿、儿童、青少年及青少年患者，可与治疗同时进行。儿科安宁疗护解决严重的医疗问题，如遗传性疾病、癌症、早产、神经系统疾病、心臟病和肺部疾病。它可以缓解这些疾病的症状，包括疼痛、气短、疲劳、便秘、噁心、食慾不振、睡眠困难、焦虑和忧郁。简而言之，我们帮助改善儿童和家庭的生活品质。儿科安宁疗护是一项跨学科合作，旨在改善患有危及生命疾病的儿童及其家人的生活品质。世界卫生组织 (WHO) 将儿科安宁疗护定义为对儿童的身体、思想和精神进行积极、全面的护理，包括对家庭的支持。在安宁疗护中最常用的药物包括扑热息痛、布洛芬、吗啡、比沙可啶、甲硝唑、多潘立酮、地塞米松和地西泮。我们也治疗肾衰竭、肌萎缩侧索硬化症 (ALS)、癌症等严重疾病，以及帕金森氏症、慢性阻塞性肺病 (COPD) 和充血性心臟衰竭 (CHF) 等慢性疾病。

市场动态

新产品的推出以及主要市场参与者不断增加的併购预计将推动全球儿科安宁疗护药物市场的成长。例如，2022年4月1日，日本製药公司卫材株式会社收购日本医疗保健区块链新创公司Arteryex Inc.，以夯实基础并快速拓展其数位解决方案业务。两家公司将共同开发并为患者、医疗保健专业人员和整个社会提供个人健康记录（PHR）相关服务。

本研究的主要特点

本报告对全球儿科安宁疗护药物市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率（CAGR）。
它还强调了各个细分市场的潜在收入成长机会，并为该市场提供了一系列有吸引力的投资主张。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
根据公司亮点、产品组合、主要亮点、绩效和策略等参数对全球儿科安宁疗护药物市场的主要参与者进行了分析。
本研究涵盖的主要公司包括Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
该报告的见解使行销人员和公司高管能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个利害关係人，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球儿科安宁疗护药物市场的各种策略矩阵，将有助于利害关係人做出决策。

Novartis International AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Anqiu Lu'an Pharmaceutical Co., Ltd.
Granules India Limited
Zhejiang Kangle Pharmaceutical Co., Ltd.
Farmson Pharmaceutical Gujarat Pvt. Ltd.
Atabay Pharmaceutical Factory
Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
Huzhou Konch Pharmaceutical Co., Ltd.
Alnylam Pharmaceuticals Inc.
Eton Pharmaceuticals, Inc.
Eisai Inc.

第10章

调查方法
关于出版商

简介目录

Product Code: CMI4251

Global pediatric palliative care drugs market is estimated to be valued at US$ 83.1 billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 83.1 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.10%	2030 Value Projection:	US$ 117.8 Bn

Pediatric Palliative Care Drugs Market - IMG1

Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson's disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).

Market Dynamics

Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.

Key features of the study:

This report provides an in-depth analysis of the global pediatric palliative care drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pediatric palliative care drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market

Detailed Segmentation:

Global Pediatric Palliative Care Drugs Market, By Drug Class:
- Analgesics
- Anti-emetics
- Laxatives
- Adjuvant Medications
- Steroids
- Sedatives
- Neuroleptic Medications
- Others
Global Pediatric Palliative Care Drugs Market, By Route of Administration:
- Oral
- Topical
- Parenteral
Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Pediatric Palliative Care Drugs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc
- Eisai Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Pediatric Palliative Care Drugs Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Anti-emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Adjuvant Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Neuroleptic Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pediatric Palliative Care Drugs Market , By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Anqiu Lu'an Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Granules India Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhejiang Kangle Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Atabay Pharmaceutical Factory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Huzhou Konch Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alnylam Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eton Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eisai Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

儿科安宁疗护药物市场：依药物类别、给药途径、通路、地区：规模、份额、前景、机会分析，2023-2030